Effect of live and inactivated Lactobacillus rhamnosus GG on experimentally induced rhinovirus colds: Randomised, double blind, placebo-controlled pilot trial

Beneficial Microbes

Volumn 6, Issue 5, 2015, Pages 631-639

  Kumpu, M ^a,b   Kekkonen, R A ^a   Korpela, R ^b   Tynkkynen, S ^a   Jarvenpaa S ^c   Kautiainen, H ^c   Allen, E K ^d,e   Hendley, J O ^d   Pitkaranta A ^b,f,g   Winther, B ^e  

^a VALIO LTD   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Medcare Foundation   (Finland)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g QATAR UNIVERSITY   (Qatar)

Author keywords

Infection; Probiotic; Respiratory; Virus

Indexed keywords

PLACEBO; PROBIOTIC AGENT; IMMUNOLOGIC FACTOR;

ADULT; ANTIBODY RESPONSE; ARTICLE; CHILL; COMMON COLD; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXPERIMENTAL INFECTION; FEMALE; FRUIT JUICE; HEADACHE; HUMAN; HUMAN EXPERIMENT; LACTOBACILLUS RHAMNOSUS; MALAISE; MALE; NORMAL HUMAN; NOSE OBSTRUCTION; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; RHINOVIRUS INFECTION; SEROCONVERSION; SNEEZING; SORE THROAT; UNSPECIFIED SIDE EFFECT; VIRUS CULTURE; VIRUS SHEDDING; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; ISOLATION AND PURIFICATION; PATHOLOGY; RHINOVIRUS; TREATMENT OUTCOME;

COMMON COLD; DOUBLE-BLIND METHOD; IMMUNOLOGIC FACTORS; LACTOBACILLUS RHAMNOSUS; PLACEBOS; PROBIOTICS; RHINOVIRUS; TREATMENT OUTCOME;

EID: 84944386559     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2014.0164     Document Type: Article

References (29)

1. Ahlroos, T. and Tynkkynen, S., 2009. Quantitative strain-specific detection of Lactobacillus rhamnosus GG in human faecal samples by real-time PCR. Journal of Applied Microbiology 106: 506-514.
2. Arruda, E., Pitkaranta, A., Witek Jr., T.J., Doyle, C.A. and Hayden, F.G., 1997. Frequency and natural history of rhinovirus infections in adults during autumn. Journal of Clinical Microbiology 35: 2864-2868.
3. Claes, I.J.J., Segers, M.E., Verhoeven, T.L.A, Dusselier, M., Sels, B.F., De Keersmaecker, S. C.J., Vanderleyden, J. and Lebeer, S., 2012. Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG. Microbial Cell Factories 11: 161.
4. Couch, R.B. 1990. Rhinovirus. In: Lennette, E.H. (ed.). Laboratory diagnosis of viral Infections. 2nd ed. Marcel Dekker, New York, USA, pp. 709-729.
5. De Vrese, M., Winkler, P., Rautenberg, P., Harder, T., Noah, C.,Laue, C., Otte, S., Hampe, J., Schreiber, S., Heller, K. and Schrezenmeir, J., 2005. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: A double blind, randomized, controlled trial. Clinical Nutrition 24: 481-491.
6. Douillard, F.P., Ribbera, A., Kant, R., Pietilä, T.E., Järvinen, H.M., Messing, M., Randazzo, C.L., Paulin, L., Laine, P., Ritari, J., Caggia, C., Lähteinen, T., Brouns, S.J.J., Satokari, R., von Ossowski, I., Reunanen, J., Palva, A. and De Vos, W.M., 2013. Comparative genomic and functional analysis of 100 Lactobacillus rhamnosus strains and their comparison with strain GG. PLoS Genetics 9: e1003683.
7. Gotteland, M., Cruchet, S. and Verbeke, S., 2001. Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans. Alimentary Pharmacology and Therapeutics 15: 11-17.
8. Gwaltney, J.M., Jr., 1992. Combined antiviral and antimediator treatment of rhinovirus colds. Journal of Infectious Diseases 166: 776-782.
9. Gwaltney, J.M., Jr., Moskalski, P.B. and Hendley, J.O., 1980. Interruption of experimental rhinovirus transmission. Journal of Infectious Diseases 142: 811-815.
10. Hamparia, V.V., 1979. Rhinoviruses. In: E.H. Lennette and N.J. Schmidt (eds.) Diagnostic procedures for viral and rickettsial infections, 5th ed. American Public Health Association, Washington, DC, USA, pp. 535-575.
11. Hao, Q., Lu, Z., Dong, B.R., Huang, C.Q. and Wu, T., 2011. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev: CD006895.
12. Hatakka, K., 2007. Probiotics in the prevention of clinical manifestations of common infectious diseases in children and in the elderly. PhD thesis, University of Helsinki, Helsinki, Finland. Available at: http://tinyurl.com/qcpbze7.
13. Hatakka, K., Savilahti, E., Ponka, A., Meurman, J.H., Poussa, T., Nase, L., Saxelin, M. and Korpela, R., 2001. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322: 1327.
14. Hojsak, I., Snovak, N., Abdovic, S., Szajewska, H., Misak, Z. and Kolacek, S., 2010. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebocontrolled trial. Clinical Nutrition 29: 312-316.
15. Jackson, G.O., Dowling, H.F., Spiesman, I.C.I. and Boand, A.V., 1958. Transmission of common colds to volunteers under controlled conditions. I. The common cold as a clinical entity. Archives of Internal Medicine 101: 267-278.
16. Kaila, M., Isolauri, E., Saxelin, M., Arvilommi, H. and Vesikari, T., 1995. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Archives of Disease in Childhood 72: 51-53.
17. Kankainen, M., Paulin, L., Tynkkynen, S., von Ossowski, I., Reunanen, J., Partanen, P., Satokari, R., Vesterlund, S., Hendrickx, A.P., Lebeer, S., De Keersmaecker, S.C., Vanderleyden, J., Hamalainen, T., Laukkanen, S., Salovuori, N., Ritari, J., Alatalo, E., Korpela, R., Mattila-Sandholm, T., Lassig, A., Hatakka, K., Kinnunen, K.T., Karjalainen, H., Saxelin, M., Laakso, K., Surakka, A., Palva, A., Salusjarvi, T., Auvinen, P. and de Vos, W.M., 2009. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proceedings o the National Academy of Sciences of the USA 106: 17193-17198.
18. Kekkonen, R.A., Vasankari, T.J., Vuorimaa, T., Haahtela, T., Julkunen, I. and Korpela, R., 2007. The effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runners. International Journal of Sport Nutrition and Exercise Metabolism 17: 352-363.
19. Kirjavainen, P.V., Salminen, S.J. and Isolauri, E., 2003. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. Journal of Pediatric Gastroenterology and Nutrition 36: 223-227.
20. Kumpu, M., Kekkonen, R.A., Kautiainen, H., Jarvenpaa, S., Kristo, A., Huovinen, P., Pitkaranta, A., Korpela, R. and Hatakka, K., 2012. Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial. European Journal of Clinical Nutrition 66: 1020-1023.
21. Kumpu, M., Lehtoranta, L., Roivainen, M., Rönkkö, E., Ziegler, T., Söderlund-Venermo, M., Kautiainen, H., Järvenpää, S., Kekkonen, R.A., Hatakka, K., Korpela, R. and Pitkäranta, A., 2013. The use of the probiotic Lactobacillus rhamnosus GG and viral findings in the nasopharynx of children attending day care. Journal of Medical Virology 85: 1632-1638.
22. Lebeer, S., Claes, I., Tytgat, H.L., Verhoeven, T.L., Marien, E., Von Ossowski, I., Reunanen, J., Palva, A., De Vos, W.M., Keersmaecker, S.C. and Vanderleyden, J., 2012. Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Applied and Environmental Microbiology 78: 185-193.
23. Lehtoranta, L., Soderlund-Venermo, M., Nokso-Koivisto, J., Toivola, H., Blomgren, K., Hatakka, K., Poussa, T., Korpela, R. and Pitkaranta, A., 2012. Human bocavirus in the nasopharynx of otitis-prone children. International Journal of Pediatric Otorhinolaryngology 76: 206-211.
24. Luoto, R., Ruuskanen, O., Waris, M., Kalliomaki, M., Salminen, S. and Isolauri, E., 2013. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial. Journal of Allergy and Clinical Immunology 13: 01307-01309.
25. Makela, M.J., Puhakka, T., Ruuskanen, O., Leinonen, M., Saikku, P., Kimpimaki, M., Blomqvist, S., Hyypia, T. and Arstila, P., 1998. Viruses and bacteria in the etiology of the common cold. Journal of Clinical Microbiology 36: 539-542.
26. Schulz, K.F., Altman, D.G. and Moher, D., 2010. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Medicine 7: e1000251.
27. Smith, T.J., Rigassio-Radler, D., Denmark, R., Haley, T. and Touger Decker, R., 2013. Effect of Lactobacillus rhamnosus LGG(R) and Bifidobacterium animalis ssp. lactis BB-12(R) on health-related quality of life in college students affected by upper respiratory infections. British Journal of Nutrition 109: 1999-2007.
28. Sybesma, W., Molenaar, D., Van IJcken, W., Venema, K. and Kort, R., 2013. Genome instability in Lactobacillus rhamnosus GG. Applied and Environmental Microbiology 79: 2233-2239.
29. Wenus, C., Goll, R., Loken, E.B., Biong, A.S., Halvorsen, D.S. and Florholmen, J., 2008. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. European Journal of Clinical Nutrition 62: 299-301.